Recent Advances of Non‐Nucleoside Polymerase Inhibitors With Broad‐Spectrum Antiviral Activities
Medicinal Research Reviews · 2026-07 · 46 (4) · 945-965
DOI: 10.1002/med.70041 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medicinal Research Reviews, online erschienen am 22.03.2026. Verfasst von Sining Tao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, Shandong Key Laboratory of Druggability Optimization and Evaluation for Lead Compounds, Key Laboratory of Chemical…. Hauptthemen laut MEDLINE: Antiviral Agents, Enzyme Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 117 Literaturangaben. Gefördert von: Taishan Scholar Program of Shandong Province, National Key Research and Development Program, Shandong Laboratory Program.
Abstract (Originalsprache)
A tremendous and painful price has been paid in the fight against pandemic viruses in the global health field. Emerging and re‐emerging viruses serve as primary drivers of severe pandemics, such as influenza virus (IV), respiratory syncytial virus (RSV), and severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). Viral polymerases are highly conserved among viruses of the same genus. Inhibitors targeting polymerases often exhibit broad‐spectrum antiviral activity against these same genus viruses, playing a crucial role in antiviral therapies. Non‐nucleoside polymerase inhibitors demonstrate their superiority in terms of safety and anti‐mutation ability out of nucleoside/nucleotide polymerase inhibitors. This review presents an overview of non‐nucleoside polymerase inhibitors along with their relative antiviral activities and mechanisms of action, providing a reference for the development of novel antiviral drugs with broad‐spectrum activities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicinal Chemistry, Shandong Key Laboratory of Druggability Optimization and Evaluation for Lead Compounds, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, S…
- School of Life Sciences, Shandong University, Qingdao, Shandong, People's Republic of China.
ORCID-Profile: Xian-Wei Wang, Xinyong Liu, Dongwei Kang
Förderung
- Taishan Scholar Program of Shandong Province
- National Key Research and Development Program
- Shandong Laboratory Program
- Qilu Young Scholars Program of Shandong University
- National Basic Research Program of China
Zitieren
APA
Tao, S., Zhou, Z., Li, X., Wang, X. W., Liu, X., & Kang, D. (2026). Recent Advances of Non‐Nucleoside Polymerase Inhibitors With Broad‐Spectrum Antiviral Activities. Medicinal Research Reviews, 46(4), 945-965. https://doi.org/10.1002/med.70041
Vancouver
Tao S, Zhou Z, Li X, Wang XW, Liu X, Kang D. Recent Advances of Non‐Nucleoside Polymerase Inhibitors With Broad‐Spectrum Antiviral Activities. Medicinal Research Reviews. 2026;46(4):945-965. doi:10.1002/med.70041
BibTeX
@article{Tao2026,
author = {Tao, Sining and Zhou, Zhenzhen and Li, Xin and Wang, Xian-Wei and Liu, Xinyong and Kang, Dongwei},
title = {Recent Advances of Non‐Nucleoside Polymerase Inhibitors With Broad‐Spectrum Antiviral Activities},
journal = {Medicinal Research Reviews},
year = {2026},
volume = {46},
number = {4},
pages = {945--965},
doi = {10.1002/med.70041}
}
EUVIMED